Disciplined Investors L.L.C. Makes New $684,000 Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Disciplined Investors L.L.C. bought a new position in UnitedHealth Group Incorporated (NYSE:UNH) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 1,263 shares of the healthcare conglomerate’s stock, valued at approximately $684,000.

Several other institutional investors have also bought and sold shares of UNH. Howard Capital Management Group LLC bought a new position in UnitedHealth Group in the 3rd quarter valued at $341,000. Principal Financial Group Inc. raised its holdings in shares of UnitedHealth Group by 11.3% in the third quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate’s stock valued at $1,039,933,000 after buying an additional 180,479 shares during the last quarter. Jacobs Levy Equity Management Inc. bought a new stake in UnitedHealth Group during the 3rd quarter worth about $319,000. Integrated Wealth Concepts LLC raised its stake in shares of UnitedHealth Group by 0.9% in the third quarter. Integrated Wealth Concepts LLC now owns 23,828 shares of the healthcare conglomerate’s stock worth $13,932,000 after acquiring an additional 207 shares during the last quarter. Finally, Motley Fool Asset Management LLC grew its stake in shares of UnitedHealth Group by 3.6% during the third quarter. Motley Fool Asset Management LLC now owns 41,606 shares of the healthcare conglomerate’s stock valued at $24,269,000 after purchasing an additional 1,449 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the company’s stock in a transaction on Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.33% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of research analysts have commented on UNH shares. Oppenheimer increased their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. Piper Sandler lowered their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a research note on Friday, January 10th. Barclays cut their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a report on Friday, January 17th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Twenty research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Trading Up 0.1 %

UNH opened at $523.61 on Thursday. The firm’s fifty day simple moving average is $509.15 and its 200 day simple moving average is $542.83. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The stock has a market capitalization of $478.95 billion, a P/E ratio of 33.78, a P/E/G ratio of 1.37 and a beta of 0.62. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter last year, the firm earned $5.83 EPS. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.60%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s payout ratio is 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.